Yesterday, in the 65th SEFH virtual Congress, a panel of 3 experts from Orphar-SEFH group and Dr. Badia from Omakase Consulting shared their experiences about Horizon Scanning reports talking about how to develop it and use it for anticipating new drugs coming to Spain. 

//Yesterday, in the 65th SEFH virtual Congress, a panel of 3 experts from Orphar-SEFH group and Dr. Badia from Omakase Consulting shared their experiences about Horizon Scanning reports talking about how to develop it and use it for anticipating new drugs coming to Spain. 

Yesterday, in the 65th SEFH virtual Congress, a panel of 3 experts from Orphar-SEFH group and Dr. Badia from Omakase Consulting shared their experiences about Horizon Scanning reports talking about how to develop it and use it for anticipating new drugs coming to Spain. 

Conference focused on the Horizon Scanning of orphan drugs report developed by Orphar-SEFH group in collaboration with Omakase Consulting. Check the full report in the following link: http://gruposdetrabajo.sefh.es/ethos/images/stories/Publicaciones/Primer_Informe_HorizonScanning_Orphar-SEFH.pdf
2020-10-21T09:18:21+00:00October 21st, 2020|News & Events|

Leave A Comment